Masood Soltanipur received his M.D. degree in Medicine from Shahed University in 2023. He is a medical doctor and researcher affiliated with the Quality of Life Department and Integrative Oncology Research Group at the Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran (2023-2024). He now serves as a General Practitioner (GP) at Ebne-sina Medical Center (2024 to now). His work in medicine and clinical research has resulted in more than 50 scientific publications and more than 200 citations. His research topics mainly include breast cancer survivorship, breast cancer-related lymphedema, cancer-related complications, quality of life, patient-reported outcomes, and therapeutic interventions. His research interests also include oncology, cardiovascular medicine, metabolic disorders, microbiome research, and multidisciplinary clinical research. He has contributed to clinical and observational studies, randomized controlled trials, systematic reviews and meta-analyses, and other multidisciplinary research projects. His research aims to advance evidence-based medicine and improve clinical outcomes and quality of life for patients affected by cancer and lymphedema. His ORCID is 0000-0001-9590-2776.
Masood Soltanipur received his M.D. degree in Medicine from Shahed University in 2023. He is a medical doctor and researcher affiliated with the Quality of Life Department and Integrative Oncology Research Group at the Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran (2023-2024). He now serves as a General Practitioner (GP) at Ebne-sina Medical Center (2024 to now). His work in medicine and clinical research has resulted in more than 50 scientific publications and more than 200 citations. His research topics mainly include breast cancer survivorship, breast cancer-related lymphedema, cancer-related complications, quality of life, patient-reported outcomes, and therapeutic interventions. His research interests also include oncology, cardiovascular medicine, metabolic disorders, microbiome research, and multidisciplinary clinical research. He has contributed to clinical and observational studies, randomized controlled trials, systematic reviews and meta-analyses, and other multidisciplinary research projects. His research aims to advance evidence-based medicine and improve clinical outcomes and quality of life for patients affected by cancer and lymphedema. His ORCID is 0000-0001-9590-2776.